Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus
- 25 July 2002
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 118 (2), 577-583
- https://doi.org/10.1046/j.1365-2141.2002.03642.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or bothBritish Journal of Haematology, 2000
- Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism: Prevalence and Association with Recurrent ThromboembolismThrombosis Research, 1999
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationThe New England Journal of Medicine, 1999
- Antiphospholipid antibodies and thrombosisThe Lancet, 1999
- Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant TherapyThe American Journal of Medicine, 1998
- Activated protein C resistance phenotype in patients with antiphospholipid antibodiesJournal of Laboratory and Clinical Medicine, 1997
- Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptivesBritish Journal of Haematology, 1997
- Development of resistance to activated protein C during pregnancyBritish Journal of Haematology, 1995
- Recurrent Venous Thromboembolism in Patients with a Partial Deficiency of Protein SThe New England Journal of Medicine, 1984
- Familial protein S deficiency is associated with recurrent thrombosis.JCI Insight, 1984